Laura Deming explains the new age of investing in longevity.

Laura Deming is the founder and full-time partner at The Longevity Fund, an early stage venture capital fund backing companies which target the ageing process to treat disease, with investments in gene editing, small molecule therapeutics, and novel methods to treat disease.